Early trial halted for rare 'Overgrowth' disease
NCT ID NCT03290092
Summary
This early-phase trial tested a drug called taselisib in people with rare, often severe, genetic overgrowth conditions. The goal was to see if the drug, which targets a specific genetic mutation, could safely control the abnormal tissue growth. The study was small and terminated early, so its effectiveness remains unclear.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PIK3CA-RELATED OVERGROWTH are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU Hôtel Dieu
Nantes, 44093, France
-
CHU La Réunion - Site GHSR
Saint-Pierre, 97448, France
-
CHU d'Angers
Angers, 49933, France
-
CHU de Bordeaux - GH Pellegrin
Bordeaux, 33076, France
-
CHU de Nancy
Vandœuvre-lès-Nancy, 54511, France
-
CHU de Nancy - Hôpital de Brabois
Vandœuvre-lès-Nancy, 54511, France
-
CHU de Nice - Hôpital l'Archet 2
Nice, 06202, France
-
CHU de Saint-Etienne Hôpital Nord
Saint-Priest-en-Jarez, 42270, France
-
Chu Dijon Bourgogne
Dijon, 21000, France
-
HCL - Hôpital femme-mère-enfant
Lyon, France
-
Hôpital Arnaud de Villeneuve
Montpellier, 34090, France
-
Hôpital Jeanne de Flandre
Lille, 59037, France
-
Hôpital Larrey
Toulouse, 31059, France
-
Hôpital Necker-Enfants malades
Paris, 75743, France
-
Hôpital Raymond Poincaré (AP-HP)
Garches, 92380, France
-
Hôpital Saint Eloi
Montpellier, 34295, France
-
Hôpital Sud
Rennes, 35203, France
-
Hôpital Trousseau
Tours, 37044, France
Conditions
Explore the condition pages connected to this study.